-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Ayala Pharmaceuticals, Inc. annual/quarterly Nonoperating Income (Expense) history and growth rate from Q1 2020 to Q3 2023.
- Ayala Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2023 was -$143K, a 14400% decline year-over-year.
- Ayala Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was -$15.7M, a 21341% decline from 2022.
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)